Evidence map›Paper›PMID 34100890›Full record

ArticleInvestigative ophthalmology & visual science2021

IGFBP-3 Mediates Metabolic Homeostasis During Hyperosmolar Stress in the Corneal Epithelium.

Evan D Bogdan, Whitney L Stuard, Rossella Titone, Danielle M Robertson

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Autophagy in ocular diseases: from mechanisms to therapeutic potential.Frontiers in cell and developmental biology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Evan D BogdanDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, Texas, United States.
Whitney L StuardDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, Texas, United States.
Rossella TitoneDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, Texas, United States.
Danielle M RobertsonDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, Texas, United States.
Southwestern Medical CenterSouthwestern Medical Center · US

Funding

Stem Cell, Organoid and Cell Phenotyping ModuleP30EY030413 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI W MATTHEW PETROLL · 2019 to 2026
$5.9M
Effects of Systemic Disease on Corneal Epithelial PathophysiologyR01EY024546 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI DANIELLE M. ROBERTSON · 2015 to 2026
$4.3M
The role of exosomes in Pseudomonas Aeruginosa Corneal InfectionR01EY029258 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI ROBERTSON, DANIELLE M. · 2019 to 2023
$1.6M
The Role of IGFBP-3 in Mitochondrial Homeostasis in the Corneal EpitheliumF30EY031559 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI SAMBHARIYA, WHITNEY STUARD · 2020 to 2022
$107k
T35 NEI Medical Student Summer Research TrainingT35EY026510 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI Benjamin Franklin Chong, DANIELLE M. ROBERTSON · 2018 to 2026
$99k
NEI NIH HHS F30 EY031559NEI NIH HHS P30 EY030413NEI NIH HHS R01 EY024546NEI NIH HHS R01 EY029258NEI NIH HHS T35 EY026510
6 · The paper itself

Abstract

Purpose: The insulin-like growth factor binding protein-3 (IGFBP-3) is a multifunctional secretory protein with well-known roles in cell growth and survival. Data in our laboratory suggest that IGFBP-3 may be functioning as a stress response protein in the corneal epithelium. The purpose of this study is to determine the role of IGFBP-3 in mediating the corneal epithelial cell stress response to hyperosmolarity, a well-known pathophysiological event in the development of dry eye disease. Methods: Telomerase-immortalized human corneal epithelial (hTCEpi) cells were used in this study. Cells were cultured in serum-free media with (growth) or without (basal) supplements. Hyperosmolarity was achieved by increasing salt concentrations to 450 and 500 mOsM. Metabolic and mitochondrial changes were assessed using Seahorse metabolic flux analysis and assays for mitochondrial calcium, polarization and mtDNA. Levels of IGFBP-3 and inflammatory mediators were quantified using ELISA. Cytotoxicity was evaluated using a lactate dehydrogenase assay. In select experiments, cells were cotreated with 500 ng/mL recombinant human (rh)IGFBP-3. Results: Hyperosmolar stress altered metabolic activity, shifting cells towards a respiratory phenotype. Hyperosmolar stress further altered mitochondrial calcium levels, depolarized mitochondria, decreased levels of ATP, mtDNA, and expression of IGFBP-3. In contrast, hyperosmolar stress increased production of the proinflammatory cytokines IL-6 and IL-8. Supplementation with rhIGFBP-3 abrogated metabolic and mitochondrial changes with only marginal effects on IL-8. Conclusions: These findings indicate that IGFBP-3 is a critical protein involved in hyperosmolar stress responses in the corneal epithelium. These data further support a new role for IGFBP-3 in the control of cellular metabolism.

Indexed as

Dry Eye SyndromesStress, PhysiologicalCells, CulturedEpithelium, CornealHomeostasisHumansInflammation MediatorsInsulin-Like Growth Factor Binding Protein 3Interleukin-6Interleukin-8MitochondriaOsmolar ConcentrationOsmotic PressureInflammation MediatorsInsulin-Like Growth Factor Binding Protein 3Interleukin-6Interleukin-8

Identifiers

PMID34100890
PMCPMC8196413
OpenAlexW3170790224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.